What's breaking now, across thousands of outlets.
Sam Waksal is doubling down on ROCK2 after his first work on the target led to the chronic graft-versus-host disease medicine Rezurock. Now, the Graviton Bioscience CEO is teaming up with a cardio drug development ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
An HIV-positive Vredenburg father who raped his 13-year-old daughter without a condom, knowing he could infect her with the virus, has been sentenced to life imprisonment for the horrific crime.
SpaceX loses latest legal fight over xAI's gas-powered data centers in Mississippi — court rejects arguments that mobile turbines are exempt from air permits
The Oncodetect® molecular residual disease test is giving clinicians insights that can reshape cancer treatment and monitoring.
Key PointsBridgeBio saw revenue climb by 193% year over year in the third quarter.
Scientists found "youthful" brain cells that may help some people resist Alzheimer's symptoms.
In a surprising discovery, scientists found that certain diets associated with obesity can make cancer immunotherapy more effective in mice, challenging traditional assumptions about diet and cancer…
